Cibus (CBUS) Change in Cash (2016 - 2025)
Cibus (CBUS) posted Change in Cash of -$14.0 million for Q4 2025, down 11.02% sequentially from -$12.6 million in Q3 2025, and up 2.85% YoY from -$13.6 million in Q4 2024.
Cibus (CBUS) Change in Cash (2016 - 2025) Analysis & Trends
Cibus has reported Change in Cash for 10 years, with the latest figure at -$14.0 million in Q4 2025.
- Quarterly Change in Cash rose 2.85% year-over-year to -$14.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.5 million (up 75.31% YoY) and the FY2025 annual result came in at -$4.5 million, up 75.31% from the prior year.
- Change in Cash declined to -$14.0 million in Q4 2025 per CBUS's latest filing, from -$12.6 million in the prior quarter.
- Over five years, Change in Cash peaked at $48.8 million in Q2 2023 and troughed at -$19.0 million in Q3 2023.
- A 5-year average of -$418300.0 and a median of -$1.3 million in 2023 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2023 and 2024: Change in Cash soared 918.24% in 2023, then slumped 1861.27% in 2024.
- Over 5 years, Change in Cash stood at -$492000.0 in 2021, then plunged by 647.76% to -$3.7 million in 2022, then jumped by 122.18% to $816000.0 in 2023, then plunged by 1861.27% to -$14.4 million in 2024, then climbed by 2.85% to -$14.0 million in 2025.
- According to Business Quant data, Change in Cash over the past three periods registered -$14.0 million, -$12.6 million, and $12.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.96 Mn |
| Sep 30, 2025 | -12.58 Mn |
| Jun 30, 2025 | 12.88 Mn |
| Mar 31, 2025 | 9.15 Mn |
| Dec 31, 2024 | -14.37 Mn |
| Sep 30, 2024 | -1.22 Mn |
| Jun 30, 2024 | 5.51 Mn |
| Mar 31, 2024 | -8.19 Mn |
| Dec 31, 2023 | 816,000.00 |
| Sep 30, 2023 | -19.01 Mn |
| Jun 30, 2023 | 48.84 Mn |
| Mar 31, 2023 | -1.47 Mn |
| Dec 31, 2022 | -3.68 Mn |
| Sep 30, 2022 | -4.71 Mn |
| Jun 30, 2022 | -5.97 Mn |
| Mar 31, 2022 | 3.46 Mn |
| Dec 31, 2021 | -492,000.00 |
| Sep 30, 2021 | -3.57 Mn |
| Jun 30, 2021 | 1.10 Mn |
| Mar 31, 2021 | -913,000.00 |